Beauty Farm Medical and Health Industry Inc. disclosed that it repurchased 36,000 ordinary shares on 28 May 2026 through on-market transactions on the Hong Kong Stock Exchange, paying an aggregate HKD 0.68 million at prices ranging from HKD 18.60 to HKD 19.15 per share (volume-weighted average: HKD 18.987).
Following the transaction: • Issued shares (excluding treasury stock) decreased from 249.33 million to 249.29 million, a reduction of 0.0144%. • Treasury shares increased to 2.30 million, keeping total issued shares unchanged at 251.59 million.
The latest purchase brings cumulative buybacks under the shareholder mandate approved on 27 June 2025 to 2.30 million shares, equivalent to 0.98% of the 235.80 million shares outstanding when the mandate was granted. The company is authorised to repurchase up to 23.58 million shares under this mandate and remains subject to a moratorium on new share issues or treasury share sales until 27 June 2026.
Comments